U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07166133) titled 'GORE(R) TAG(R) Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study' on Sept. 02.
Brief Summary: A prospective multi-center post-market study collecting outcomes through at least 5-years and up to 10-years post procedure for subjects treated with the TBE Device in Zone 0/1 as part of routine clinical practice.
Study Start Date: March, 2026
Study Type: INTERVENTIONAL
Condition:
Aortic Arch Dissection
Aortic Arch Aneurysm
Intervention:
DEVICE: GORE(R) TAG(R) Thoracic Branch Endoprosthesis
Lesions in aortic arch in Zone 0 or Zone 1
Recruitment Status: NOT_YET_RECRUITING
Sponsor: W.L.Gore & Associates
Disclaimer: Curat...